PRESTIGE CONSUMER HEALTHCARE (PBH)
US74112D1019 - Common Stock
PRESTIGE CONSUMER HEALTHCARE
NYSE:PBH (4/24/2024, 7:21:46 PM)
After market: 70.13 0 (0%)70.13
-1.09 (-1.53%)
Company Profile
Prestige Consumer Healthcare, Inc. engages in the marketing, sale, and distribution of pharmaceutical drugs and consumer products. The company is headquartered in Tarrytown, New York and currently employs 560 full-time employees. The company went IPO on 2005-02-10. The firm operates through two segments: North American OTC Healthcare and International OTC Healthcare. Its diverse portfolio of brands include Monistat and Summer’s Eve women's health products, BC and Goody's pain relievers, Clear Eyes and TheraTears eye care products, DenTek specialty oral care products, Dramamine motion sickness treatments, Fleet enemas and glycerin suppositories, Chloraseptic and Luden's sore throat treatments and drops, Compound W wart treatments, Little Remedies pediatric over-the-counter products, Boudreaux’s Butt Paste diaper rash ointments, Nix lice treatment, Debrox earwax remover, and others.
Company Info
PRESTIGE CONSUMER HEALTHCARE
660 White Plains Rd
Tarrytown NEW YORK 10591
P: 19145246800
CEO: Ronald M. Lombardi
Employees: 560
Website: https://www.prestigebrands.com/
PBH News
22 days ago - Prestige Consumer Healthcare Inc.Dramamine® Celebrates its 75th Anniversary by Reviving an Unexpected Partner: The Barf BagThe nausea-fighting brand is highlighting the cultural impact of barf bags and ushering them into a new era with a documentary, a limited-edition collection of upcycled bags and a custom wearable art piece made from vintage bags
The nausea-fighting brand is highlighting the cultural impact of barf bags and ushering them into a new era with a documentary, a limited-edition...
3 months ago - Prestige Consumer Healthcare Inc.Prestige Consumer Healthcare Inc. Reports Third Quarter Fiscal 2024 ResultsRevenue of $282.7 Million in Q3, Up 2.6% Versus Prior YearDiluted EPS of $1.06 in Q3, Up 2.2% Versus Prior YearReduced Leverage Ratio to 2.9x at Quarter...
3 months ago - Prestige Consumer Healthcare Inc.Insight Pharmaceuticals Issues Voluntary Nationwide Recall of TING® 1% Tolnaftate Athlete’s Foot Spray Antifungal Spray Liquid Due to the Presence of BenzeneTARRYTOWN, N.Y., Feb. 02, 2024 (GLOBE NEWSWIRE) -- Insight Pharmaceuticals, a Prestige Consumer Healthcare Inc. company (“Insight”), is voluntarily...
PBH Twits
Here you can normally see the latest stock twits on PBH, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits:
